Seres Therapeutics, Inc. Short-term Investments
Seres Therapeutics, Inc. (MCRB) had Short-term Investments of $0 as of 2023-12-31, per its 8-K filed 2024-08-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2024-08-15
- 2023-12-31: Short-term Investments $0.00.
- 2023-09-30: Short-term Investments $0.00.
- 2023-06-30: Short-term Investments $0.00.
- 2023-03-31: Short-term Investments $11.70M.
| Period end | Short-term Investments |
|---|---|
| 2023-12-31 | $0.00 8-K · filed 2024-08-15 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $11.70M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $18.31M 8-K · filed 2024-08-15 |
| 2022-09-30 | $27.61M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $68.97M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $94.81M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $110.70M 10-K · filed 2023-03-07 |
| 2021-09-30 | $119.93M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $140.56M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $176.22M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $137.57M 10-K · filed 2022-03-01 |
| 2020-09-30 | $90.59M 10-Q · filed 2020-11-09 |
| 2019-12-31 | $29.69M 10-K · filed 2021-03-02 |
| 2018-06-30 | $38.11M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $75.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $113.89M 10-Q · filed 2018-08-02 |
| 2017-09-30 | $125.27M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $137.57M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $145.17M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $138.70M 10-K · filed 2018-03-08 |
| 2016-09-30 | $147.77M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $152.03M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $110.05M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $131.15M 10-K · filed 2017-03-16 |
| 2015-09-30 | $149.64M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $55.44M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $0.00 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |